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Abstract 
The information concerning the relationship of 
hypouricemia with urinary tract stones is limited. We 
investigated the incidence and types of hypouricemia, 
and also studied its relationship to urinary tract stones. 
Hypouricemia was detected in 3 out of 1520 outpatients 
(0.20%). The loading tests using pyrazinamide, pro-
benecid and benzbromarone showed that uric acid ab-
sorption was impaired before tubular secretion in two 
cases and incomplete postsecretory reabsorption in one 
case. Complication of urinary tract stone was found in 
two cases. The composition of the stones was mixed 
calcium oxalate and uric acid. Hypouricemia should be 
recognized as one of the causes of kidney stone 
formation. 
Key Words: Renal tubular hypouricemia, incidence, 
calcium urolithiasis, pyrazinamide loading test, pro-
benecid loading test, benzbromarone loading test, hyper-
uricosuria, diet. 
• Address for correspondence: 
Tadashi Kotake 
Department of Urology, 
Teikyo University School of Medicine, 
Ichihara Hospital, 3426-3 Anesaki, 
Ichihara, Chiba 299-01, Japan 
Telephone No.: 81-436-62-12 l l ext. 2824 
FAX No.: 81-436-61-4773 
417 
Introduction 
While hyperuricemia is well known to be associat-
ed with calcium nephrolithiasis (Smith et al., 1969), 
only limited information is available on the relationship 
of hypouricemia with urinary tract stones (Kawabe et 
al., 1976). Hypouricemia provides important clues for 
explaining the mechanism of renal urate handling. We 
investigated the incidence and types of hypouricemia, 
and also studied its relationship to urinary tract stones. 
Subjects and Methods 
The subjects studied were three hypouricemic pa-
tients screened from 1520 outpatients who received 
blood biochemistry tests between May, 1986 and April, 
1990 at the Urology Department of Teikyo University 
Hospital in lchihara. Hypouricemia was defined as 
serum uric acid concentration of 2mg/dl or less. Two of 
these patients had urinary tract stones. Informed con-
sents were obtained from these patients. 
Throughout the study, the patients were maintain-
ed on a regular hospital diet. Uric acid in serum and 
urine was determined by automated colorimetric proce-
dure with use of a uricase-peroxidase system. Pyrazina-
mide suppression test was performed, using previously 
described procedure (Shichiri et al., 1982, 1985). Brief-
ly, renal clearance of urate and creatinine prior to and 
following oral administration of 3.0 g pyrazinamide 
were measured. Probenecid test and benzbromarone test 
were done using the same procedure, with the exception 
that 1.5 g probenecid and 200 mg benzbromarone were 
given orally instead of pyrazinamide, respectively. 
These tests were undertaken on the morning following an 
overnight fast. Bladder catheterization was avoided by 
oral hydration with 500 ml water before study. Normal 
control data were obtained from two healthy male volun-
teers. A 14-day period was allowed between tests to 
avoid pharmacologic interference. The various parame-
ters of urate handling were calculated according to 
Steele and Rieselbach ( 1967). Other measurements in-
volved 24-hour urine chemistry, copper metabolism and 
urinary amino acids. 
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Table 1. Clinical features and uric acid metabolism. 
Case Case 2 Case 3 Controls 
Age (years) 47 62 36 36 30 
Sex male male female male male 
Occupation truck driver farmer house-wife 
Sur (mg/di) 0.9 0.8 1.5 6.5 6.3 
Cur (mg/min) 60 61 19 6.3 5.8 
Ccr (mg/min) 118 97 99 95 102 
FEurate (%) 56 60 19 6.1 5.7 
Urine pH 5.5-7.0 5.5-7.0 5.5-7.0 5.0-6.5 5.0-7.0 
Stone formation ( +) (-) (+) (-) (-) 
Values are mean of 3 determinations. 
Abbreviations used are: Sur: serum uric acid level; Cur: uric acid clearance; FEurate: Cur/Ccr x 100. 
Table 2. Urine chemistry in patients with hypouricemia 
Case 1 Case 2 Case 3 Control values • 
Cre (mg/24 hr) 1430 980 1050 1820±710 
Ca (mg/24 hr) 221 226 88 189± 59 
p (mg/24 hr) 750 900 575 1020±270 
Mg (mg/24 hr) 83 187 67 88± 22 
UA (mg/24 hr) 640 830 440 750±290 
Na (mEq/24 hr) 185 150 135 254± 90 
K (mEq/24 hr) 46 53 39 62± 17 
Cl (mEq/24 hr) 198 145 125 268± 86 
Values are mean of two determinations; •oata obtained from 13 male volunteers (mean ± standard deviation). 
Abbreviations used: Cre: creatine, UA: uric acid 
Results 
Incidence of hypouricemia 
Hypouricemia was detected in 3 out of 1520 
ambulatory patients (0.20%). 
Clinical data 
Clinical features, uric acid metabolism and the 
type of renal tubular defects are summarized in Table 1. 
All patients had no urinary tract infection and did not 
take any medicine. Urine chemistries of the 3 patients 
are listed in Table 2. The amount of uric acid excreted 
in urine was not reduced. Urinary amino acids excretion 
was within normal limits. Serum copper and lead levels 
were also normal. There was no evidence that these pa-
tients had malignancies (such as lung cancer, multiple 
myeloma and Hodgkin's disease) by radiographical and 
hematological examinations. 
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Loading tests to identify the site of disturbance 
(a) Pyrazinamide loading test: FEurate (the 
ratio of uric acid clearance to creatinine clearance) 
failed to respond to pyrazinamide in Cases 1 and 2, 
while it approached O in Case 3 as in the healthy control 
(Fig. l). 
(b) Probenecid loading test: Initial rate of 
FEurate increase was identical in patients as well as 
controls, but plateau was reached early on in patients 
compared to controls (Fig. 2). 
(c) Benzbromarone loading test: As in the pro-
benecid test, FEurate slowly increased (Fig. 3). 
It was inferred from the above results that uric 
acid absorption was impaired before tubular secretion in 
Cases 1 and 2, while incomplete postsecretory reabsorp-
tion occurred in Case 3. 
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Figure 1. Results of the pyrazinamide suppression test. 
Complication of stone and its components 
Two of 3 hypouricemic patients had urinary tract 
stones. The composition of the stones was mixed calci-
um oxalate and uric acid, the latter predominating (55 % 
in Case 1, 89% in Case 3). 
Discussion 
Hypouricemia is generally considered to be pre-
sent if the serum uric acid level is continuously 2.0 
mg/dl (Kelley, 1975) or less, although 1.5 mg/di is 
thought to be more appropriate as the lower limit for the 
Japanese (Sasaki, 1980). Its incidence among the Japa-
nese population is estimated at 0.15-0.56% (Hisatome et 
al., 1989; Sasaki, 1982). Consistent with this rate, 3 
out of 1520 patients (0.20%) were found to have hypo-
uricemia in our survey. The incidence is said to be 
higher in Japanese than in Caucasians. Idiopathic hypo-
uricemia is frequently congenital, with no sex difference 
in its incidence. It is considered an autosomal recessive 
inherited disease (Frank et al., 1979; Weitz et al., 
1980), although some authors reported it as dominantly 
inherited (Suzuki et al., 1981). Familial occurrence was 
not noted in our cases. Hypouricemia occurring in di-
minished production of uric acid is best known in a con-
genital defect of xanthine oxidase. In idiopathic hypo-
uricemia, the transport of uric acid in the kidney is im-
paired. Hypouricemia may be secondary to such dis-
eases as severe liver damage, Wilson's disease, Fanconi 
syndrome, abnormality in antidiuretic hormone (ADH) 
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Figure 3. Results of the benzbromarone test. 
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tumors such as liver cancer, lung cancer, Hodgkin's 
disease and multiple myeloma (Weinstein et al., 1965; 
Tykarski, 1988; Mitnick and Beck, 1979). All our pa-
tients showed a normal urinary excretion of amino acids. 
Serum ADH, copper, ceruloplasmin and lead were also 
normal. As chest X-ray, abdominal CT and fluoroscopy 
of the stomach were all negative, it seemed unlikely that 
a malignant tumor was present. In one patient who had 
a superficial bladder tumor, hypouricemia remained un-
changed two years after complete excision of the tumor 
by transurethral resection. Tumor recurrence was de-
nied by endoscopic examinations. Since they all had 
been healthy and had not received the drug in the past, 
hypouricemia associated with the drug was ruled out. 
Alcohol consumption was 180 ml/day of Japanese Sake 
in Case 2, and almost nothing in Cases 1 and 3. More-
over, the findings suggestive of renal tubular disturbance 
were not obtained, such as glycosuria, proteinuria and 
persistent acidosis. From these findings, ali 3 patients 
were considered to have idiopathic hypouricemia. This 
may be partly explained by the fact that our cases were 
detected by the screening of outpatients, not by testing 
of inpatients. 
For the mechanism of uric acid excretion from the 
kidney, the theory of a 4-component system (Rieselbach 
and Steele, 1974) is most widely supported. The 4 com-
ponents refer to a complete filtration through the glom-
eruli, reabsorption before secretion, secretion at the 
renal tubules, and reabsorption after secretion. Finally, 
6-10% of the filtrate is excreted in urine. The sites of 
disturbance at renal tubules can be classified into several 
types by the loading tests using pyrazinamide, which 
blocks uric acid secretion at renal tubules (Gutman et 
al., 1969), probenecid (De Vries and Sperling, 1979) 
and benzbromarone, which block reabsorption after se-
cretion. The loading tests revealed that hypouricemia in 
our patients was caused by a disturbance of reabsorption 
before secretion in two, and incomplete postreabsorption 
in the other. Since renal stones developed in both types, 
the formation of stones seemed not to be related to the 
site of disturbance of uric acid transport. 
Hypouricemia produces few symptoms, and is 
usually discovered by chance. The only complication is 
urinary tract stones. The frequency of urinary stones in 
hypouricemia was reported to be 16% (Sasaki et al., 
1986), but it was present in as many as 2 of our 3 cases. 
In our 2 cases with stones, urinary uric acid and FEurate 
were lower than in the stone-free case. When hypouri-
cemic patients take purine-rich diet, they will temporari-
ly excrete excessive uric acid with the resulting consid-
erable elevation of the urinary uric acid level even if the 
24-hour uric acid excretion is normal. Urinary uric acid 
is said to increase roughly in proportion to the oral in-
take of purine. In our cases, urinary uric acid measure-
ment after a high purine diet was not performed. We 
are going to do this type of study. It might be possible 
that the patients who had stones took more purine-rich 
food temporarily than the stone-free patient. Purine 
binges might be risky in the case of hypouricemia. The 
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formation of calcium stones may also be affected by the 
oxalate (Ito et al., 1992) and crystal growth inhibitors 
(Ito and Coe, 1977) in urine. 
It is generally considered that no treatment is 
needed for hypouricemia. However, since idiopathic hy-
pouricemia patients are said to be susceptible to acute 
renal failure (Ishikawa et al., 1990, Numabe et al., 
1992) it is necessary to warn these patients of the possi-
ble danger of exercise and dehydration, and to follow 
them up. Acute renal failure in such a case seems to re-
sult from the obstruction of renal tubules by uric acid 
crystals, as exercise accelerates uric acid formation 
(Sutton et al., 1980) and the crystals of uric acid are ac-
cumulated within renal tubules if dehydration follows ex-
ercise. If urinary tract stones are present, dietary meas-
ures or the use of allopurinol will become necessary to 
reduce temporary hyperuricosuria which will increase 
the risk of stone formation. 
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Discussion with Reviewers 
Reviewer II: Would the authors explain the double par-
adox of urate stone formation in the absence of hyperuri-
cosuria and the absence of stones in the patients with the 
highest uric acid excretion? Do the authors assume that 
purine binges are a necessary and sufficient condition to 
account for urate stone formation? What is the relation-
ship with calcium oxalate? Would the authors speculate 
on the specificity and nature of the tubular biochemical 
defect? 
Authors: We do not think that purine binges are a nec-
essary and sufficient condition to account for urate stone 
formation, but they may be very important. The theory 
of hyperuricosuric calcium oxalate stone formation is 
already established. 
Reviewer IV: Unfortunately, uric acid levels were 
lower in 2 of the 3 cases studied than in stone-free 
cases. This observation strongly opposes the authors' 
view that intake of purine rich diet will result in hyper-
uricosuria in such patients and needs to be justified by 
results of urinary uric acid measurement after a high 
purine diet. 
Authors: As a next step we will measure the urinary 
urate levels after a purine load. It will be important to 
see the magnitude of the temporary hyperuricosuria. 
